In this section, we will describe primarily additional studies to validate the technique for NAS identification, and additional analyses performed on the datasets of identified NAS.
2006). In this study, the TAL1/SCL locus (a region of 250kb) was analyzed systematically for the presence of DNaseI HSS by the use of DNA microarrays, and 17 DHS were identified (Follows et al., 2006) . Of those genomic regions, eight (47%) were also identified as NAS in our analysis (fig. S17B). Among the NAS that non overlapped a DHS (7 additional sites), we noticed that two of these NAS were also identified in CD4+ cells as DHS (Boyle et al., 2008) , suggesting that these sites are accessible in CD34+ cells, and further remodelled during lymphoid differentiation. To identify functional elements shared among different cell types, we compared CD34 NAS with previously published datasets of DHS. Recently, the most complete dataset of DHS in human cells was reported, representing 94,925 sites in resting T Cells (Boyle et al., 2008) . We found an extensive overlap between our dataset of NAS with the dataset of CD4+ cells DHS, accounting for 17% (21, 765) of the NAS from the CD34+ derived library. Indeed, DHS in different cells have been proposed to be shared within a range (22-39%) compatible with our own observations (Xi et al., 2007) . Approximately 50% of the regions overlapping in the CD34+ NAS library and the CD4+ DHS dataset were also present in the CD34-NAS library. We note, however, that the NAS (21,325) from the CD34-library that overlap the DHS dataset in T-cells constitute only 6.3% of the entire CD34-NAS library, suggesting that these cells have a rather different pattern of accessibility (fig. S17C). Functional cis-regulatory elements can be also identified using non-enzymatic methods, like the FAIRE methodology: this technique has been used to identify genomic elements accessible in formaldehyde cross-linked fibroblasts chromatin, the majority of which (51%) are not overlapping with DHS (Giresi et al., 2007a) . We found a significant overlap among our libraries and those derived using FAIRE ( fig. S17D ). Remarkably, the overlap between our datasets of NAS and either the CD4+ dataset of DHS or the FAIRE sites was exactly the same as the overlap between DHS and FAIRE (32.3% for NAS vs FAIRE; 33% for CD4+DHS vs FAIRE). The identification of DHS and FAIRE sites, generated in different cell lines, is a direct evidence of the capacity of our technology to reveal cis-regulatory elements shared among different cell lines. In addition, since DHS and FAIRE sites are retrieved using remarkably different approaches, they may represent different types of chromatin structure, highlighting the utility of our method to reveal distinct types of chromatin states.
Chromosomal Distribution of NAS Correlates with Both Chromosomal Length and Gene Density
The chromosomal distribution of NAS showed a strong correlation with chromosomal length (r=0.897) and gene number, though to a lesser extent (r=0.628; fig. S18 ). This result might reflect both functional and structural requirements, leading to the presence of NAS in both gene-rich and genepoor areas. In this analysis we found that specific chromosomes (chr. 19 and chr. X) behave as outliers in the correlation of NAS with chromosome length in chromatin-derived libraries. These chromosomes are also known to behave as outliers in their replication timing in lymphoblastoid cell lines, suggesting a different chromatin organization (Cohen et al., 2006; Woodfine et al., 2004) .
A Comparison between the Number of NAS within the Promoter Region and Gene Expression Levels
To compare the number of NAS at the promoter with the gene expression levels, we counted the number of distinct NAS found within 5kb surrounding the TSS of each gene and asked if genes with the highest number of NAS belong to the highest group of expression (in this analysis, we used CD34-cells to increase statistical confidence, because the number of available NAS is higher than in CD34+ cells). We observed a striking, regular increase in the number of NAS related to groups with increasing gene expression level, strongly supporting the idea that genes with high transcriptional rate are indeed more accessible in terms of number of discrete NAS at the TSS and its immediate neighbourhoods ( fig. S19 ).
CD34+ Chromatin Shows High Levels of H3.3, and Low Levels of Macro H2A Histone Variants, Compared to CD4+ Differentiated Cells
Our data show that differentiated cells (e.g, CD34-cells) have less accessible chromatin than multipotent progenitors (CD34+ cells). Although this observation is consistent with previous theoretical models, derived from experimental data such as gene expression profiles and, more obviously, from cytological analyses, our data -directly measuring chromatin accessibilityrepresent a strong experimental support of these models. To prove that gross difference among diverse stages of hematopoietic differentiation occur in vivo, we have analyzed expression levels of the histone variants associated with different states of chromatin accessibility in three progressive stages of hematopoietic development (CD34+, CD19+ and CD4+ cells), in the same donor. In bone marrow, CD19 surface marker staining occurs on immature B-cells (not yet committed to full differentiation; e.g. expressing IgM) (Bertrand et al., 1997) ), thus representing an heterogeneous population with different degrees of differentiation. In contrast, only differentiated T-helper cells do express the CD4 surface marker. The total level of the histone H3.3 variant -associated with open chromatin-is higher in CD34+ cells, whereas the heterochromatin associated variant macroH2A is increased in CD4+ cells ( fig. S20 ), while CD19 showed a pattern more similar to CD34+ cells. This result confirms a trend towards a more compact chromatin structure at advanced stages of differentiation, and indirectly suggest that the number of accessible regions is indeed lower in these cells.
SUPPLEMENTAL DISCUSSION
In this section, we address a few additional points which further extend the impact of the Na-Seq technology developed, and of the results obtained.
NA-Seq: In Silico Prediction of Genomic Coverage
One concern raised by the use of restriction enzymes on a genomic scale is that they could underestimate the number of accessible sites in the genome due to their sequence specificity. We have shown that sequence-specific REs can be used to cover the entire genome with very high resolution, while avoiding the problems deriving from the use of non-specific nucleases (such as DNaseI). Bioinformatic analyses indicate that the argument that REs will miss accessible areas when the RE recognition site is absent does not constitute a limitation. For example, a dataset of 9,218 core promoters bound by PolII in ChIP-chip (Kim et al., 2005) was widely covered (80%) using just one nuclease (HpaII). In addition, genome-wide analyses for NlaIII (ie. CATG) showed that non-promoter DNA has -on average -a recognition site every 300bp. Since DHS range in size from 200-2000bp (Boyle et al., 2008 , our NAS libraries (generated by using both NlaIII and HpaII) offer a thorough coverage, and the miss of actual sites should occur very infrequently. Another concern when using nucleases in vivo is that NAS libraries prepared from native non cross-linked chromatin may result in higher background, due to nuclease cut of randomly exposed DNA. A recent report suggest that this is not the case, as chromatin is stable under in vitro conditions, allowing mononucleosomes to be sequenced in high throughput (Schones et al., 2008) . We have also extensively validated (experimentally, and by comparison to available datasets) our NAS libraries, reaching the conclusion that they provide a high fidelity picture of the accessibility status of chromatin. In fact, 80% of the NAS can be considered as bona fide hypersensitive sites, since they score positive in a DNaseI-based assay.
NAS Represent Different Functional States of the Chromatin, and Occur Frequently in the Genome
The limited redundancy (about 20%) and overlap (18%) of our libraries suggest that 2x10 8 reads -i.e. the extent of a single 454 run when we performed the experiments-are not sufficient to sequence in deep the entire set of NAS present in a given cell type. How many NAS do exist in the genome? We addressed this question applying a Capture-Recapture statistical estimation (see supplementary experimental procedures): basically, the estimate is based on the degree of redundancy between two consecutive reads sets generated from two distinct 454 sequencing runs from the same library of NAS from CD34-cells. In this analysis, we considered only non-redundant NlaIII reads (to estimate how many different genomic loci are indeed accessible to NlaIII) and inferred the total number of reads as 1. 3±0.1x10 6 . This number is indeed much higher than (for example) the number of DHS found in T cells (less than 100,000 sites). The difference can be explained by: a) differences in accessible regions among different cell types (CD4+ cells represent a terminally differentiated cell, and their chromatin could be more compact); b) additional chromatin features recognized by REs, reflecting different biophysical properties between REs and DNaseI; c) different methodological and statistical analyses employed. More generally (see also figure 2A and main Discussion), our results support the view that the NA-Seq technology (unlike DHS mapping) has the potential to represent more faithfully different states of chromatin conformation. Importantly, both the positive control regions and the NAS identified from our library showed a rather broad range of sensitivity to DNaseI ( fig. 2A ,C; table S2), when using high-sensitivity qPCR-based DNaseI analyses (Dorschner et al., 2004; McArthur et al., 2001) . Gradations in accessibility to nucleases reflect, among other things, genome functional state-dependent differences in the extent of chromatin remodeling (Zaret, 1984) . Functional cis-regulatory elements, chromatin remodelling at functional elements can also result in mild form of accessibility not represented among DHS (Reinke and Horz, 2004; Wood and Felsenfeld, 1982) . Thus, the nucleus is well known to contain "strong" as well as "weak" DHS. Principal component analysis of accessibility of NAS in a DNaseI-PCR assay ( fig. 2B : see legend for a detailed description of the method), the clustering approach and subsequent visualization via Clusplot (Pison, 1999) separated NAS in three distinct groups (D1, D2 and D3). D1 NAS show a high sensitivity to DNaseI, with increasing amounts of enzyme proportionally decreasing the PCR signal. D2 NAS display initial resistance to degradation, followed by rapid decrease of the signal with increasing enzyme concentrations and hence probably represent "weak" DHS. Finally, D3 NAS showed a constantly decreasing signal, which never resulted in more than half of reduction compared to controls: these NAS may represent regions which are heterogeneous in accessibility (either inter-allelically, or inter-cellularly). Altogether, our data -obtained both experimentally and through data miningconfirm the quality of our NAS libraries, and reveal their coverage of different elements within the genome, characterized by their accessibility at different degrees, perhaps reflecting different nuclear functions. Given the potential ability of RE to recognize linker DNA, a subset of our NAS might also indicate areas where nucleosome positioning takes place (Reinke and Horz, 2004) . This phenomenon has been shown to largely affect the specificity of DNaseI-based genome-wide studies, where positioned nucleosomes where targeted frequently and contributed to the high background observed (70%) (Boyle et al., 2008) . In all cases, we consider functionally relevant the additional information gained from the actual cutting sites in vivo, especially when changes are observed. Indeed, conveying the information from different types of chromatin structures has been instrumental for the identification of large-scale transitions in chromatin accessibility. Finally, with respect to the third point, we note that our analysis produce merged NAS measuring less than 0,5kb in most of the cases, whereas the DHS dataset from CD4+ cells identify larger genomic fragments in many instances (Boyle et al., 2008) . For example, in the TP53 upstream region, we mapped at least 5 discrete NAS in CD34+ cells by Southern blotting using HpaII as RE, while we could detect three distinct DHS ( fig. S16 ). In the genome-wide analysis performed in CD4+ cells, these sites were combined into one, due to statistical considerations ( fig. S16 ). This is also the case in other instances: in 13.2% to 17.6% of the "single" CD4+ DHS we found two or more NAS (CD34-and CD34+ cells, respectively). Furthermore, we note that DHS did not show a sharp correlation between promoter hypersensitivity and associated gene expression (Boyle et al., 2008) , except than with highly expressed genes. In contrast, REs equally access promoters irrespectively of gene expression levels ( fig. S18 ). We therefore assume that this difference, at least in part, can be reconciled considering the higher resolution (due to lower background) reached with our approach. Nonetheless, the presence of a high number of accessible regions might represent (from the standpoint of genome architecture) a similar finding to the functional observation of promiscuous and widespread presence of transcriptional units within the entire genome (ENCODE Project Consortium, 2007) .
Functional Annotation of NAS along the Genome
In contrast to DHS found by DNaseI-Seq, NAS are not biased for the 5' end of the genome and, in general, are more evenly distributed. We consider of high relevance the finding that the vast majority of sites lie in intergenic regions, away from annotated genes. There are several possible explanations for the abundance of potential regulatory elements in intergenic regions: a) several regulatory elements for annotated genes may be distal in terms of primary sequence from their "target" gene, but topological features (i.e., DNA looping) may put them in contact with promoter areas (Lee et al., 2006; Spilianakis et al., 2005) ; b) intergenic regions may contain undiscovered, unannotated genes (or non coding-RNA transcript), which may reduce the actual percentage of "intergenic" regions (ENCODE Project Consortium, 2007) ; c) perhaps more importantly, recent genome-wide studies of RNA transcription have revealed that essentially all of the genome has the potential to be transcribed, and therefore unanticipated levels of transcriptional regulation of non-coding regions should be envisioned (ENCODE Project Consortium, 2007) . In addition, NAS are found close to TSS independently from their status of gene expression ( fig. S18 ), suggesting that in these regions DNA is exposed to pioneer transcription factors even in the absence of active transcription. Finally, we have not observed enrichment of NAS over the transcriptional termination site, even though we indeed mapped several sites at the 3'-end of genes ( fig. S13C ). This led us to conclude that regulatory elements may exist at the end of gene units, but their position is not strictly related to transcription.
SUPPLEMENTAL EXPERIMENTAL PROCEDURES
In Vitro Differentiation Protocol Purification of CD34+ cells from G-CSF mobilized patient leukaphereses was performed using anti-CD34 antibody conjugated with magnetic beads (StemCell Technologies, Vancouver, BC). Following isolation of mononuclear cells from blood samples on a FicollPAQUE gradient, beads were used according to the manufacturer protocol. After purification, 200,000 cells were stained using a FITC-conjugated anti-CD34 (or left unstained) to verify the purity of each preparation (in most of the cases >98%). CD34+ depleted leukaoheres were further processed to isolate CD19+ B and CD4+ T cells, respectively. The remaining cells were counted and resuspended in fresh serum-free media (HPMG, Cambrex), at a concentration of 250,000 to 500,000 cells per ml, in 100mm non-adherent plates. The following cytokines were then added: human recombinant thrombopoietin (TPO), Stem Cell Factor (SCF), Interleukin-6 (IL-6), Flt3-L, G-CSF and GM-CSF, all at 100 ng/ml (all cytokines are from Peprotech). Medium was changed every other day, and cells were resuspended at a concentration of 250,000 to 500,000 cells per ml. At Day 7, medium was implemented with normal AB human pooled serum (Invitrogen), and cells were collected before starting to adhere to plates (on average 10 days). Adherent cells were not collected.
Preparation of Library of NAS
Cells were collected, washed twice with ice-cold PBS, and centrifuged for 5 min at 500g at 4°C. 1x10 7 cells were resuspended in 5 ml ice-cold homogenization buffer (10 mM Tris-Cl pH 7.4, 15 mM NaCl, 60 mM KCl, 5% sucrose, 1 mM EDTA, 0.1 mM EGTA, 0.1% NP-40, 0.15 mM spermine, 0.5 mM spermidine, 1 mM DTT, 0.5 mM PMSF) and cell membranes were ruptured by 4-5 strokes on ice in a Wheaton homogenizer. The homogenate was transferred to a fresh tube and 1 ml of a sucrose "pad" solution (10 mM Tris-Cl pH 7.4, 15 mM NaCl, 60 mM KCl, 10% sucrose, 1 mM EDTA, 0.1 mM EGTA, 0.15 mM spermine, 0.5 mM spermidine, 1 mM DTT, 0.5 mM PMSF) was added to the homogenate to form a layer underneath it. The nuclei were pelleted at 140g at 4°C for 20 min. Nuclei were gently resuspended in ice-cold digestion buffer (10 mM HEPES pH 7.5, 25 mM KCl, 5 mM MgCl2, 5% glycerol, 0.15 mM spermine, 0.5 mM spermidine, 1 mM DTT, 0.5 mM PMSF) to a density of 2 x10 7 nuclei/ml, incubated at 37°C for 1 min, and then treated with 1/10th v/v of NlaIII or HpaII (NEB, 50,000 units/ml) for 5 min. at 37°C. The reaction was stopped by adding 0.5M EDTA to reach a final concentration of 25mM. The solution was gently mixed with an equal volume of 1% PFGE-grade low melting point agarose (InCert, BMC) prepared in 1x PBS and cooled to 55°C. The nuclei-agarose mixture was carefully aspirated into the barrel of a 1 ml tuberculin syringe from which the tapered tip had been completely cut off to form a cylindrical plug. Once the agarose had solidified, the plug was incubated at 50°C for 36 hours with gentle rocking in 5 plug volumes of 0.5 M EDTA, 1% SDS, 10 mM Tris-Cl pH 8.0, 0.5 mg/ml proteinase K (PCR-grade, Roche). The digestion buffer was changed once during the incubation. The plug was washed 3 times for 10 min each at room temperature in 1x TE buffer, pH 8.0, and proteinase K was then inactivated by incubating in 1x TE, 1 mM PMSF, for 1 hr at 37°C. The agarose plug was equilibrated with 3 volumes of Sau3A I buffer (NEB) for 30 min. on ice, the buffer was replaced with 2 volumes of fresh Sau3A I buffer containing 10 µg/ml RNAse A and 1/10th volume of high-concentration Sau3A I (20 units/µl). The reaction proceeded at 37°C for 24 hrs with gentle rocking. The plug was then washed 3x with 1 x TE at room temperature (10 min.) each, and DNA was purified placing the plug into the well of a 0.8% agarose gel (Amresco), electrophoresing the DNA out of the plug into the gel, staining with SYBR Gold, visualization on a non-UV transilluminator ("Dark Reader"), and gelpurification using a standard gel extraction kit (Qiagen). Following preparation of the library, appropriate oligonucleotides were ligated to the DNA fragments. The 44-base primer sequences (hereafter referred to as "adaptors") were double-stranded oligonucleotides comprised (from 5' to 3') of a 20 base PCR amplification template, followed by a 20 base sequencing primer, and a 4 base, nonpalindromic sequencing "key" comprised of one of each deoxyribonucleotide (e.g. AGTC). Two classes of adaptors, termed "adaptor A" and "adaptor B", were used in each reaction. The A and B adaptors differed in both nucleotide sequence and the presence of a 5' biotin tag on the B adaptor. The adaptor pairs were designed to allow directional ligation to the NAS: A: CCATCTCATCCCTGCGTGTCCCATCTGTTCCCTCCCTGTCTCAG; B:/5BioTEG/CCTATCCCCTGTGTGCCTTGCCTATCCCCTGTTGCGTGTCTC AG. Directionality was achieved as the 3' sticky side of the adaptor ligated to the cohesive end of each NAS, while the 5' overhang prevented ligation to the PCR primer region of the adaptor. We employed modified 454 A and B adaptors to enrich for the genome DNA fragments that contained the paired enzyme cut sites at the 5' and 3' ends during library preparation. These sites are NlaIII-Sau3a for the NlaIII chromatin digestion and HpaII-NlaIII for the HpaII chromatin digestion. Using this strategy enable us to generate >99.6% of all sequenced reads with a bona-fide NlaIII recognition sequence at the 5' end (CATG). HpaII libraries had a lower rate of conversion where between 31-43% of reads possessed a 5' HpaII recognition sequence (CGG). Subsequent to the ligation of modified 454 adaptors the library preparation protocols were as described by Marguiles et al. and the manufacturers guidelines. The unassembled 454 reads were mapped to the NCBI version 35 human genome sequence using BLASTN (parameters W=20), subsequent to lower case repeat masking (RepeatMasker). All alignments of at least 25bp with ≥80% sequence identity were retained and the reads that either possess unique genomic alignments or the loci of their best alignment were identified. On average, some 35% of reads could not be aligned in this manner and extensive analysis revealed that >95% of these were almost exclusively transposon repeat sequences. Conservation between the human and mouse genomes were determined by aligning the sequence of mapped NAS to the mouse genome (NCBI version 30). Alignment parameters were modified to assign an equal weight to match and mis-match alignment position and regions were post-processed to identify those that contain ≥50bp aligned with ≥70% sequence identity. Databases of well-annotated genes, TSS, 3'-end, CpG islands, evolutionary conserved sequences, were all obtained by UCSC genome browser (http://genome.ucsc.edu/cgi-bin/hgGateway).
Calculating NAS Distribution across the TSS of RefSeq Genes using Kernel Density
Each NAS was annotated as pairs of genomic coordinates in a single multiline text file (in UCSC BED format). The genomic coordinates were then used to sequentially query a local mirror of the UCSC MySQL RefGene database by using a Perl script. Next, NAS were annotated with respect to RefSeq genes (within a 2.5Kb interval), and both gene name and distance in base pairs were reported. Distances were calculated either from TSS or TES depending on the relative position of NAS boundaries (the closest one). The kernel density estimation is implemented in R through the density function and the kde2d function, and was used to extrapolate the data to the entire NAS population. To measure the relative enrichment of NAS across 5Kb spanning either TSS or TES, we employed the distances measured in the previous step. A distribution curve was then plotted with a kernel density function. We chose a bandwidth smoothing of 100 and n=100 number of windows (check 'R' 'density' function documentation for details. Such annotation was further used to draw a chromosomal/genomic landscape of accessible regions. NAS were grouped by their relative position respect to RefSeq genes and tagged by category: in gene, upstream, downstream (relative to TSS of RefSeq genes; +2.5Kb) and intergenic.
NAS Clusterization, CTCF and NRSF Overlaps
Each NAS in the genomic space was defined by its start, which coincide with the NlaIII/HpaII cut site, its end (the end of the sequencing reaction), a strand and a chromosome. Many sites partially or fully overlap with each other. We have merged together overlapping or very close sites (in this case we merged together all the NAS overlapping 1 basepair). In most of the analysis we further merged NAS when targeting the same genomic region (600bp on either direction). The interval of 600bp was chosen on the basis of the average size of DHS (Boyle et al, 2008) . To ensure correct overlapping with other datasets, coordinates from publicly available libraries (CTCF and NRSF binding sites) were also merged together allowing the same overlap of 600bp.
Merged
Gene Profiling Procedures
RNA was purified using TRizol reagent (Invitrogen) followed by RNeasy Mini kit (Qiagen). Three independent samples for CD34+ cells and two for CD34-cells were obtained, and amplified/labelled by standard procedures. Then, cRNA sample were hybridized to Affymetrix UG133A 2.0 plus arrays. All expression data were normalized by using RMA (Irizarry et. al 2003) via the BioConductor project's Affymetrix package (http:/www.bioconductor.org). Mean of the three chips was used to compute expression level for each probeset (tot. 54675). Validation of the expression data by qPCR was performed on a random subset of genes (correlation was found for 34/37 -91.9% of the genes tested). To identify RefSeq genes having NAS in the 2.5Kb upstream/ downstream region, we employed NAS annotation with respet to RefSeq genes TSS (see above). RefSeq accession numbers have been translated in equivalent Affymetrix probesets using the UCSC table "Known To Affy". These Affymetrix identifiers served us as a sub-list of candidate genes from the whole set of probes deposited on the arrays. Expression values from different sub-lists have been compared using statistical tools provided by 'R'. 'Box and whisker' and bar plot were used to provide a graphical interpretation. We next splitted genes in ten groups, each representing a decile of expression (1 st decile lowest, 10 th decile highest), and ranked them according to their expression level (as recorded in the chip). To build up the distribution in fig.5E , NAS position with respect to TSS was then used to plot a distribution profile.
DNaseI Hypersensitivity Assays qPCR DNaseI analysis of NAS identified by sequencing of the original CD34+
and CD34-derived libraries was carried out on several new, independent preparations. Nuclei were split into four 200µl aliquots; one of the aliquots (no DNase) was immediately lysed with 200µl of buffer AL (DNeasy Tissue & Blood DNA purification kit; Qiagen) and set aside. The remaining three aliquots were treated with DNaseI (80, 40 and 20U/ml, Roche) for 2 min at 18°C. Genomic DNA was then purified following the manufacturer's instructions. Primers were designed according to previously published methods by using Primer3. Twenty nanograms of DNaseI-treated and non digested DNA were amplified in 20µl reactions with SyberGreen PCR mix (Applied Biosystem), using a final primer set concentration of 900 nM, and ran on an ABI7700 real-time PCR machine. Values were normalized against the starting amount of DNA for each amplicon (set as 1.0), and -to increase reproducibility against different samples-then subjected to a second normalization round against the amount of DNaseI-resistant DNA of a region which has been identified as not sensitive to DNaseI digestion (clone N2). As positive controls of DHS, we have analyzed five different regions known to be DNaseI-sensitive in HSPC (HS1, HS2 and HS5 of the ß-globin locus, see Jimenez, et al, 1992 and our unpublished observations in CD34+ cells). Southern blot analysis of DNaseI and RE sensitivity was carried out following standard procedures.
Chromatin Immunoprecipitation Analysis
ChIP was performed essentially as described in (Frank et al., 2001) . Briefly, cells were cross-linked with 1% formaldehyde in PBS for 10 min. at 37°C, and quenched in 125 mM glycine in culture medium for 5 min at 4°C. The cells were collected by centrifugation and sonicated in lysis buffer (0,33% SDS, 150mM NaCl, 10 mM EDTA, 50 mM Tris•HCl pH 8.0, 1x protease inhibitor cocktail) to generate chromatin fragments of ~500 bp in length. The material was clarified by centrifugation, diluted 10-fold in dilution buffer (0.5% Triton X-100, 2 mM EDTA, 150 mM NaCl, 20 mM Tris•HCl, pH 7.9, 1x protease inhibitor cocktail), and pre-cleared with protein A-agarose beads.
The pre-cleared, chromatin-containing supernatant was used in immunoprecipitation reactions with the primary antibodiesdescribed below. The immunoprecipitated genomic DNA was cleared of protein and residual RNA by digestion with proteinase K and RNase A, respectively. The DNA was then extracted with DNA purification kit (Quiagen). For gene-specific ChIP analyses, quantitative real-time PCR (qPCR) was used to determine the enrichment of immunoprecipitated material relative to the input material using gene-specific primer sets to the specified regions. Immunoprecipitated DNA from 5x10 6 cell equivalents was resuspended in 0.5 ml of 10 mM Tris at pH 8.0. Real-time PCR was performed with 9,6µl of DNA per reaction and 200 nM primers, diluted in a final volume of 20µl in SYBR Green Reaction Mix (Perkin Elmer, Boston, MA). Each ChIP experiment was performed at least three times with independent chromatin isolates to ensure reproducibility. The antibodies used for ChIP were the following. From Santa Cruz (Santa Cruz, CA): CTCF (sc28198) and anti-HA antibody (sc-805; Santa Cruz). From Bethyl Lab (Montgomery, TX): NRSF, (A300-539 and A300-540). From AbCam (Cambridge, UK): ab4441 H3K9ac; ab7766 H3K4me2; ab3594 H3K79me2; ab8895 H3K4me1; ab9050 H3K36me3; ab8580 H3K4me3; H3K9me3; and ab1791 H3; From Upstate (Millipore): 06-866 H4pan-ac; 06-599 H3pan-ac; 07-449 H3K27me3 and CTCF (Upstate 07-729).
Clusterization Analysis of Histone PTMs
Data analysis was performed using GeneSpring GX (Agilent). For the heatmap of Fig. 3A , DNA recovery values for each ChIP (percentage of input DNA) were normalized to those of total H3 for 92 sites. Normalized histone marks values and DNaseI-treated DNA recovery values were log transformed (base n) and standardized to the mean of zero and unit variance. Missing values were imputed using a nearest-neighbour averaging method. Hierarchical clustering was generated by computing distances based on Spearman's rank and using an average linkage method.
Reporter Assay
Conserved non-coding sequences (CNS) present in our CD34+ derived NAS library, or non-CNS found accessible in our assay (as controls) were PCR amplified and cloned into the pGL3 SV40 promoter luciferase vector (Promega). DNA was transfected in triplicate into KG1a cells by electroporation (960uF, 230V; BioRad GenePulser II). A beta-galactosidase expressing plasmid was used for normalization of transfection efficiency. After 24h, cells were lysed and luciferase activity was measured using a luminometer (Victor III, Perkin-Elmer/Wallace).
Statistical Procedures Principal Component Analysis
Principal component analysis (PCA) of CD34+ NAS used Partitioning Around Medoids algorithm and Clusplot visualization. Data points are from qDNase assay results described in (Fig. 2A) , right panel. Partitioning used two components (accessibility at high doses, and low doses), which together explain >95% of the variance of the data, allowing a 2D plot visualization. The number of data points for each cloud is summarized in the inset (D1, high sensitivity; D2 medium sensitivity; D3, low sensitivity).
Estimation of the total number of NAS
The estimation of the total number of NAS present in the CD34-library was obtained by measuring the overlap of two samples obtained from the same library through the application of the Lincoln Index -capture-recapture method (Lincoln, 1930) (Adams, 1951) .
Comparison of accessibility across different NAS libraries
We calculated the average accessibility of wide DNA regions (optimal size was defined as described below) by weighting the number of reads within any given region per the total number of reads found in the library. Changes in frequency (accessibility) between libraries were so evaluated by means of an independent sample χ 2 test, comparing all paired frequencies.
Determination of optimal window length for comparison of NAS libraries.
To GENOME LENGTH / (NAS/5) • GENOME LENGTH = 3,08E+09 bp We scaled the window size up to 1,2Mb keeping in account that: 1) (Thurman et al., 2007) used to define discrete active and repressed functional domains ranging from about 20 kb to 1 Mb in size; the same order of magnitude has been also suggested by (Dillon, 2003) , suggesting the existence of multi-gene functional domains spanning up to "hundreds of kilobases" within human and other vertebrate genomes.
2)
as reads tend to cluster in only a part of the DNA windows, more than 50% of the 120 kb windows account for less than 5 sites, while 1,2Mb allowed actual counts of more than 10 observation in about 95% of cases.
3)
where there is only 1 degree of freedom (as with comparison of the same window between different libraries), by many authors the approximation is considered not reliable if expected frequencies are below 10 a. Then we set the significance threshold for Type I error to a probability of 0.001, thus overwhelming possible stochastic effects in identifying statistically differently accessible DNA regions.
Comparison of differential accessibility among NAS libraries
Based on the foregoing statistics, to analyze the distribution of both the differential accessibility in CD34+ and CD34-cells and of clustered-regulated genes throughout the genome, we used a sliding window of 1.2Mb (accessibility) or 0,5Mb (expression), moving stepwise (10 Kb) along the genome. Regions with significant accessibility for each cell type were located at loci where the χ 2 analysis allowed reaching at least the p<0.01 and, thus, identifying 307 total loci in either cell type. The script used to perform this analysis is available upon request.
Analyses of Gene expression profiles
Five Affymetrix chip (GeneChip HGU133Plus2) were background corrected and normalized using Affymetrix Microarray Suite, MAS5 algorithm as in (Hubbell et al., 2002) , quality and control steps were performed using Simpleaffy package (Gentleman et al., 2004) . For subsequent analyses, chips were corrected for background and normalized using RMA (Irizarry et al., 2003) . Bioconductor Simpleaffy package (Gentleman et al., 2004 ) was used to compute fold change and mean expression of samples. R v.2.5.0, 2007, was used to draw a 'box and whisker' plot for both CD34+ and CD34-gene expression. Each probeset present on the array was flagged depending on the relative changes in expression: hence, probesets were assigned to CD34+ or CD34-according to the highest expression level detected in either sample. Averaged expression levels (log base 2) were then used to compute summarized statistic and draw box plots. Boxes widths are proportional to the actual number of genes flagged as CD34+ or CD34-. Accordingly, the number of genes for each dataset determined the width of the related box while the expression level (in terms of fold changes), indicated the height of the box ( fig.  S8A ). Analyses in fig.4C and 4D report the average expression of transcript positioned near NAS (within the range ±2500bp from TSS) in CD34+ and CD34-, which resulted significantly higher -P<<0.001 -than the average rate of all other genes available on Affymetrix U133A plus 2.0. More specifically: 1) Average expression of all genes in CD34+ versus genes associated with NAS in CD34-: W = 71288077, p-value < 2.2e-16 2) Average expression of all genes in CD34+ versus genes associated with NAS in CD34+: W = 6251681, p-value = 0.000282 The 2,361 genes positioned near NAS in CD34+ cells showed an expressione level statistically different from other tissues by ANOVA (F=2.32; d.f. 5 & 14260; P<0.05) and so did NAS_CD34-by means of a paired-samples t test (avg 1.016 & 1.039; t = -9.87; d.f. 2360; P<<0.001). To compare gene expression profiles obtained employing Affymetrix U133A plus 2.0 and Affymetrix U133, we only considered 24,000 common probes. An ANOVA test was performed on the CD34+ cells, CD34-cells, and three data sets obtained on heart, kidney and liver from GEO database (http://www.ncbi.nlm.nih.gov/geo/). (Boyle et al., 2008) . HGU133Plus2 GeneChips were corrected for background, and normalized using RMA. Notice that the width and the height of each box correspond to the number of genes and their expression level, respectively, in the 50% of cases around the median. (B) Example of independent normalization using Mas5 (Affymetrix Microarray Suite 5 algorithm). Numbers in the left column represent the total present calls (%), and the signal purity (number; 100 -background noise) for each GeneChip. Scaling factors used for normalization are reported in the rightboxed column (low expressed genes have higher scaling factor) and visualized in the blue-filled box. Figure S9 . Differential Accessibility Landscapes of CD34+ and CD34-Cells The statistical significance of differential accessibility between CD34+ and CD34-cells is evaluated through the value assumed by the χ² statistic, shown as red line. Changes in frequency (accessibility) between libraries were evaluated by comparing paired NAS frequencies through an independent sample χ² test, in every subsequent 1.2Mb window. Sliding genomic windows (1.2Mb-wide) depicted peaks in accessibility by 10kb steps along each chromosome. The significance threshold for type I error was set to a p < 0.001.
Figure S10. Control of Specificity for the Analysis in Figure S9
The same methodology described in fig. S9 was applied to two separate 454 runs of the CD34-derived library (CD34+ and CD34-frequency are also shown as green and blue track, respectively). 
Figure S16. Analysis of NAS and DHS at the TP53 Upstream Region
We present here a series of analyses performed on the TP53 upstream region, which has been selected as a routinely positive control for all our nuclear preparations from CD34+ and CD34-cells. In the upper panels, as probes of accessibility we used either HpaII for increasing times (right), or DNaseI at increasing concentrations (right). Southern blot and indirect-end labelling detected three major hypersensitive areas (red asterisks between the two blots and red bars below the map) in the region contained in the EcoRI fragment (3,7kb) of the TP53 promoter (a map is shown below). The molecular weight DNA marker used during electrophoresis is indicated on the left part of the blot. The location of the three DHS, the radioactively labelled Southern probe, the NAS identified by NA-Seq in CD34+ and CD34-cells, and the DHS area identified by DNaseI (Boyle et al., 2008) are reported in the map. Note that the resolution of NA-Seq resembles more closely the Southern blot analysis than the DNaseI high throughput sequencing approach. (Giresi et al., 2007b) overlapping the CD34+/CD34-NAS datasets, and the previously cited CD4+ DHS dataset. General accessibility of chromatin in CD34+ cells results: a) on a global scale, in a loose nuclear structure; b) in a "basal", low level of gene expression for a high number of genes, which in turn facilitates the cellular differentiation upon external stimuli. Viceversa, changes in chromatin, which restrict the accessibility to genes of a specific lineage, may render committed cells more prone to repond to specific stimuli, leading to an "activated" state of gene expression. On a global scale, these changes are reflected in a more compact nuclear structure.
